Min Luo

2.4k total citations · 2 hit papers
25 papers, 2.0k citations indexed

About

Min Luo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Min Luo has authored 25 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Min Luo's work include interferon and immune responses (10 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Min Luo is often cited by papers focused on interferon and immune responses (10 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Min Luo collaborates with scholars based in China, United States and Hong Kong. Min Luo's co-authors include Jinming Gao, Zhaohui Wang, Zhijian J. Chen, Yang-Xin Fu, Yang Li, Gang Huang, Jayanthi Lea, Chensu Wang, Hua Wang and Matthew R. Porembka and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Min Luo

24 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A STING-activating nanovaccine for cancer immunotherapy

2017 752 citations Min Luo, Hua Wang et al. Nature Nanotechnology profile →
Prolonged activation of innate immune pathways by a polyvalent STING agonist

2021 240 citations Suxin Li, Min Luo et al. Nature Biomedical Engineering profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Min Luo China	16	1.2k	820	786	427	289	25	2.0k
Flávia Castro Portugal	16	753 0.6×	499 0.6×	285 0.4×	554 1.3×	242 0.8×	31	1.6k
Sachiko Hirosue Switzerland	16	933 0.8×	787 1.0×	282 0.4×	560 1.3×	137 0.5×	21	1.7k
Joshua C. Doloff United States	19	445 0.4×	824 1.0×	392 0.5×	283 0.7×	208 0.7×	40	1.7k
Junhua Mai United States	25	554 0.5×	1.1k 1.4×	595 0.8×	534 1.3×	472 1.6×	58	2.1k
Ashish Kulkarni United States	24	696 0.6×	674 0.8×	702 0.9×	306 0.7×	275 1.0×	56	1.7k
Sean A. Dilliard United States	8	422 0.3×	2.2k 2.7×	441 0.6×	219 0.5×	452 1.6×	9	2.8k
Ying‐Li Luo China	22	440 0.4×	1.1k 1.4×	625 0.8×	256 0.6×	407 1.4×	37	1.9k
Chaojun Song China	22	448 0.4×	637 0.8×	258 0.3×	201 0.5×	103 0.4×	81	1.4k
Meir Goldsmith Israel	22	462 0.4×	1.4k 1.7×	391 0.5×	170 0.4×	455 1.6×	35	2.0k

Countries citing papers authored by Min Luo

Since Specialization

Citations

This map shows the geographic impact of Min Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Luo more than expected).

Fields of papers citing papers by Min Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Luo. The network helps show where Min Luo may publish in the future.

Co-authorship network of co-authors of Min Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Min Luo. A scholar is included among the top collaborators of Min Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Luo. Min Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Lü, Liting You, Zhenfei Bi, et al.. (2025). Chitosan activates NLRP3 inflammasome and cGAS-STING to suppress cancer progression through hexokinase 2 dissociation and mitochondrial dysfunction. Theranostics. 15(16). 8473–8487.

Wang, Miao, Qihang Ding, Min Luo, et al.. (2025). A Mitochondrion‐Targeted NIR‐II Modulator for Synergistic Ferroptosis–Immunotherapy. Small. 21(22). e2501397–e2501397. 1 indexed citations

Li, Wei, Xia Xiao, Xiaoyan Sun, et al.. (2025). Case Report: Summary of multiple CAR-T expansions in anti-BCMA/GPRC5D bispecific CAR-T cell therapy for multiple myeloma. Frontiers in Immunology. 16. 1607778–1607778. 1 indexed citations

Yang, Wenshuo, Chen Chen, Min Luo, et al.. (2025). Fueling IgA‐Dominated Humoral Immunity with an Intranasal Hybrid Tumor Vaccine to Opsonize and Strike Epithelial Breast Cancer. Advanced Materials. 37(35). e2500631–e2500631. 1 indexed citations

Luo, Min, et al.. (2024). Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis. Frontiers in Pharmacology. 15. 1429709–1429709. 1 indexed citations

Lyu, Meng, Min Luo, Jingyun Li, et al.. (2023). Personalized Carbon Monoxide‐Loaded Biomimetic Single‐Atom Nanozyme for Ferroptosis‐Enhanced FLASH Radioimmunotherapy. Advanced Functional Materials. 33(51). 44 indexed citations

Lu, Tianqi, Ziqi Zhang, Zhenfei Bi, et al.. (2023). TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway. Journal for ImmunoTherapy of Cancer. 11(3). e005430–e005430. 35 indexed citations

Li, Suxin, Min Luo, Zhaohui Wang, et al.. (2022). Abstract P049: ONM-501 ― A synthetic polyvalent STING agonist for cancer immunotherapy. Cancer Immunology Research. 10(1_Supplement). P049–P049. 5 indexed citations

Chen, Fangmin, Tianliang Li, Huijuan Zhang, et al.. (2022). Acid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer. Advanced Materials. 35(10). e2209910–e2209910. 93 indexed citations

10.

Li, Suxin, Min Luo, Zhaohui Wang, et al.. (2021). Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nature Biomedical Engineering. 5(5). 455–466. 240 indexed citations breakdown →

11.

Li, Guangchao, Jintao Guo, Yanfang Zheng, et al.. (2021). CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells. Molecular Therapy — Oncolytics. 22. 507–517. 40 indexed citations

12.

Tan, Yanan, Jian‐Dong Huang, Min Luo, et al.. (2021). Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor. Cancer Letters. 522. 238–254. 27 indexed citations

13.

Yin, Weimin, Yuwei Li, Yunqing Gu, & Min Luo. (2020). Nanoengineered targeting strategy for cancer immunotherapy. Acta Pharmacologica Sinica. 41(7). 902–910. 31 indexed citations

14.

Luo, Min, Fang Wang, Hong Zhang, et al.. (2020). Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer. Signal Transduction and Targeted Therapy. 5(1). 141–141. 38 indexed citations

15.

Miller, Jason, Min Luo, Hua Wang, et al.. (2020). P857 ONM-500 – a novel STING-activating therapeutic nanovaccine platform for cancer immunotherapy. Poster presentations. A7–A8. 1 indexed citations

16.

Luo, Min, Zhida Liu, Xinyi Zhang, et al.. (2019). Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy. Journal of Controlled Release. 300. 154–160. 83 indexed citations

17.

Wang, Dangge, Tingting Wang, Haijun Yu, et al.. (2019). Engineering nanoparticles to locally activate T cells in the tumor microenvironment. Science Immunology. 4(37). 224 indexed citations

18.

Luo, Min, Hua Wang, Zhaohui Wang, et al.. (2017). A STING-activating nanovaccine for cancer immunotherapy. Nature Nanotechnology. 12(7). 648–654. 752 indexed citations breakdown →

19.

Luo, Min, et al.. (2017). Synthetic nanovaccines for immunotherapy. Journal of Controlled Release. 263. 200–210. 102 indexed citations

20.

Wang, Chensu, Hanspeter Niederstrasser, Peter M. Douglas, et al.. (2017). Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan. Nature Communications. 8(1). 2270–2270. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact